[1] Davenport A. Changes in N- terminal pro- brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients [J]. Am J Nephrol, 2012,36(4):371-376. [2] 曾蜀春,简讯,胡诗德,等. 连续性肾替代联合血液灌流治疗重症 感染AKI的临床疗效观察[J].西部医学,2015,27(2):203-205. [3] 胡秀梅. 高通量血液透析与低通量血液透析的透析效果比较[J]. 中国医药指南,2011,9(16):111-112. [4] Chang TI, Kang EW, Lee YK, et al. Higher peritoneal protein clearance as a risk factor for cardiovascular disease in peritoneal dialysis patient [J]. PLoS One, 2013,8(2): e56223. [5] Liu X, Dewei D, Sun S, et al. Treatment of severe IgA nephropathy:mycophenolate mofetil/prednisone compared to cyclophosphamide/prednisone [J]. Int J Clin Pharmacol Ther, 2014,52(2):95-102. [6] Bouki KP, Katsafados MG, Chatzopoulos DN, et al. Inflammatory markers and plaque morphology:Anoptical coherence tomography study [J]. Int J Cardiol, 2012,154(3): 287-292. [7] 朱再志,许志忠,邹茜婷,等. 连续性血液净化联合血液灌流治疗 中毒合并急性肾损伤的前瞻性研究[J]. 西部医学,2012,24(8): 1531-1533. [8] Rost NS, Biffi A, Cloonan L, et al. Brain natriuretic Peptide predicts functional outcome in ischemic stroke [J]. Stroke, 2012,43(2):441-445.